You are here: Industry Insights > Appointment

News List

AMAG Appoints Pharmacovigilance VP contractpharma
April 26, 2017
Simon brings more than 20 years of pharmaceutical industry experience
Ipsen Appoints Dr. Alexandre Lebeaut as Executive Vice-President, R&D, and Chief Scientific Officer americanpharmaceuticalreview
April 17, 2017
Ipsen has announced the appointment of Dr. Alexandre Lebeaut as Executive Vice-President, R&D, and Chief Scientific Officer, effective immediately.
Repros Names Dillaha its Permanent President and CEO americanpharmaceuticalreview
April 12, 2017
Repros Therapeutics Inc.® has announced that the Company’s Board of Directors has appointed Larry Dillaha, M.D., the President and Chief Executive Officer of the Company, effective immediately.
Allergan Names Senior Vice President of Global Investor Relations & Strategy americanpharmaceuticalreview
April 10, 2017
Allergan has announced that Daphne Karydas will join the Company as Senior Vice President of Global Investor Relations and Strategy, effective April 17, 2017.
Piramal Pharma Solutions Appoints CCO contractpharma
March 21, 2017
Needleman responsible for driving all global business development activities
Arena Pharmaceuticals Appoints Executive Vice President, Research and Development and Chief Medical americanpharmaceuticalreview
March 21, 2017
Arena Pharmaceuticals, Inc. has announced the appointment of Dr. Preston Klassen, M.D., M.H.S. as Executive Vice President, Research and Development and Chief Medical Officer. Dr. Klassen will report to Amit Munshi, Arena's President and Chief Executive O
BMS appoints Dr Thomas J. Lynch, Jr., Executive Vice President and Chief Scientific Officer cphi-online
March 10, 2017
He succeeds Dr Francis Cuss, 62, who will retire from the company.
Sartorius LPS Division Names Marketing & Sales SVP contractpharma
March 10, 2017
MacKay has a broad international background in the biopharma business
Celerion Appoints CMO contractpharma
February 23, 2017
Dr. Hoffman brings more than 28 years of experience in the pharma, device, and CRO industries
Bristol-Myers Squibb appoints three new independent directors worldpharmanews
February 22, 2017
Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has appointed Robert J. Bertolini, Matthew W. Emmens and Theodore R. Samuelsto its Board of Directors, effective immediately.

Previous page 1 2 3 4 5 Next page